These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30980714)

  • 21. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
    Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
    JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
    Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Xie D; Yang YX
    Adv Ther; 2021 May; 38(5):2586-2598. PubMed ID: 33844132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Law CCY; Koh D; Bao Y; Jairath V; Narula N
    Inflamm Bowel Dis; 2020 Nov; 26(12):1796-1807. PubMed ID: 32047894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
    Chen C; Hartzema AG; Xiao H; Wei YJ; Chaudhry N; Ewelukwa O; Glover SC; Zimmermann EM
    Inflamm Bowel Dis; 2019 Jul; 25(8):1417-1427. PubMed ID: 30839057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort.
    Macaluso FS; Sapienza C; Ventimiglia M; Renna S; Cottone M; Orlando A
    Scand J Gastroenterol; 2019 Sep; 54(9):1102-1106. PubMed ID: 31491360
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.
    Lobatón T; Ferrante M; Rutgeerts P; Ballet V; Van Assche G; Vermeire S
    Aliment Pharmacol Ther; 2015 Aug; 42(4):441-51. PubMed ID: 26104047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
    Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunistic Infection in Hospitalised Patients with Inflammatory Bowel Disease.
    Zhou JQ; Meng ZM; Zhang T; Jing XT; Gan HT
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):1015-1020. PubMed ID: 33143819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients.
    Naganuma M; Fujii T; Kunisaki R; Yoshimura N; Takazoe M; Takeuchi Y; Saito E; Nagahori M; Asakura K; Takebayashi T; Watanabe M
    J Crohns Colitis; 2013 May; 7(4):308-13. PubMed ID: 22819592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
    Yu H; MacIsaac D; Wong JJ; Sellers ZM; Wren AA; Bensen R; Kin C; Park KT
    Aliment Pharmacol Ther; 2018 Feb; 47(3):364-370. PubMed ID: 29164650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
    Chaparro M; Garre A; Ricart E; Iglesias-Flores E; Taxonera C; Domènech E; Gisbert JP;
    Aliment Pharmacol Ther; 2019 Feb; 49(4):419-428. PubMed ID: 30637837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Casanova MJ; Chaparro M; García-Sánchez V; Nantes O; Leo E; Rojas-Feria M; Jauregui-Amezaga A; García-López S; Huguet JM; Arguelles-Arias F; Aicart M; Marín-Jiménez I; Gómez-García M; Muñoz F; Esteve M; Bujanda L; Cortés X; Tosca J; Pineda JR; Mañosa M; Llaó J; Guardiola J; Pérez-Martínez I; Muñoz C; González-Lama Y; Hinojosa J; Vázquez JM; Martinez-Montiel MP; Rodríguez GE; Pajares R; García-Sepulcre MF; Hernández-Martínez A; Pérez-Calle JL; Beltrán B; Busquets D; Ramos L; Bermejo F; Barrio J; Barreiro-de Acosta M; Roncedo O; Calvet X; Hervías D; Gomollón F; Domínguez-Antonaya M; Alcaín G; Sicilia B; Dueñas C; Gutiérrez A; Lorente-Poyatos R; Domínguez M; Khorrami S; Muñoz C; Taxonera C; Rodríguez-Pérez A; Ponferrada A; Van Domselaar M; Arias-Rivera ML; Merino O; Castro E; Marrero JM; Martín-Arranz M; Botella B; Fernández-Salazar L; Monfort D; Opio V; García-Herola A; Menacho M; Ramírez-de la Piscina P; Ceballos D; Almela P; Navarro-Llavat M; Robles-Alonso V; Vega-López AB; Moraleja I; Novella MT; Castaño-Milla C; Sánchez-Torres A; Benítez JM; Rodríguez C; Castro L; Garrido E; Domènech E; García-Planella E; Gisbert JP
    Am J Gastroenterol; 2017 Jan; 112(1):120-131. PubMed ID: 27958281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases.
    Buckley LH; Xiao R; Perman MJ; Grossman AB; Weiss PF
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):215-220. PubMed ID: 31646743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
    Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Shah R; Ho EY; Kramer JR; Richardson P; Sansgiry S; El-Serag HB; Hou JK
    Dig Dis Sci; 2018 Jun; 63(6):1551-1557. PubMed ID: 29663266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.